To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open-
High-
Low-
Prev. Close-
Avg. Traded Price-
Volume-

MARKET DEPTH

info2
Total bid0.00
Total ask0.00
OrdersQtyBid
AskQtyOrders

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

695.552 days ago
730.00a day ago
arrow

LOWER/UPPER CIRCUITS

559.35
838.95
arrow
Amrutanjan Health Care Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 7.29%, in the last year to ₹469.5 Cr. Its sector's average revenue growth for the last fiscal year was 10.62%.
noteAnnual Net Profit,rose 13.03% in the last year to ₹50.83 Cr. Its sector's average net profit growth for the last fiscal year was 36.73%.
notePrice to Earning Ratio,is 38.24, lower than its sector PE ratio of 40.55.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 14.94%
Net profit growth 5Y CAGR : 12.9%
Amrutanjan Health Care Ltd Top mutual funds holding
arrow

About Amrutanjan Health Care Limited 

Amrutanjan Health Care Limited is a historic Indian wellness brand established in 1893, best known for its iconic pain balms and an expanding portfolio across over-the-counter (OTC) healthcare, women’s hygiene, and rehydration beverages. Over time, the Company has diversified beyond pain relief into congestion management, sanitary napkins under the Comfy brand, and Electro+ oral rehydration solutions, besides operating a pain management centre  . A notable milestone came in 2011 with the acquisition of the Fruitnik brand, marking its entry into beverages; other milestones include the launch of hydrogel-based pain relief patches (2019), Period Pain Relief Roll‑on (2023), and a stream of Electro+ WHO‑ORS formats (2025).

 

The Company manufactures at ISO 9001‑certified OTC units compliant with GMP and the Drugs and Cosmetics Act, and produces beverages at an ISO 22000‑certified plant. It has also set up a cGMP‑certified allopathic division to make OTC monograph topical products for export to the United States and other regulated markets . Operations span 3 plants and 6 offices in India and 1 international office, with markets served across 28 States and 19 countries; exports contributed 1.67% of turnover in the reporting year ended March 31, 2025. The Company reported zero subsidiaries, joint ventures, or associate companies during the year under review.

 

Amrutanjan Health Care Limited Key milestones

  • 2011: “Pure Healthy Essence” corporate repositioning; Comfy sanitary napkins launch; Fruitnik acquisition.
  • 2019: Amrutanjan Advanced Pain Relief Patch (India’s first hydrogel‑based patch).
  • 2023: Period Pain Relief Roll‑on.
  • 2024–2025: Relief Hot Drink, Comfy Slim Fit; Electro+ WHO‑ORS in Tetra Pack and Powder; Electro+ 160 ml pack.

 

Amrutanjan Health Care Limited Key Management

  • S Sambhu Prasad – Chairman & Managing Director
  • N Swaminathan – Chief Financial Officer
  • Gagan Preet Singh – Company Secretary & Compliance Officer

 

Latest Updates on Amrutanjan Health Care Limited 

  • Product innovation: Launch of Amrutanjan Faster Relaxation Roll‑on 2.5 ml at Rs 20; Electro+ WHO‑ORS in Tetra Pack and Powder; Electro+ Rehydrate 160 ml at Rs 25.
  • Women’s hygiene: Comfy continues to scale via a private‑label partnership; a dedicated sanitary‑napkin manufacturing plant is being developed in Hyderabad to build in‑house capacity and strengthen supply chain resilience.
  • Go‑to‑market and distribution: Effective monthly outlet coverage increased 6%, lines sold rose 32%, and stockist network expanded 1%. Marketing investments included TV and digital campaigns and regional partnerships (e.g., Bigg Boss Kannada), with large‑scale sampling across categories (over 4 lakh for pain management; 2.2 lakh for Comfy; 1.4 lakh for Electro+) .
  • Category performance: Pain management grew 6% overall; body pain volume rose 19.6%. Rehydration grew 10%; women’s hygiene recorded 18% growth; brand Relief rose 14% and Relief Mint 40% during the year.
  • Capability building: A team of medical representatives was deployed to engage doctors; SAP’s transportation module was implemented to digitise the supply chain up to the stockist point. Security enhancements included a Security Operations Centre going live and upgraded email security protocols (DKIM, SPF, DMARC).
personal

Grow your wealth with more research recommendations

+91

Frequently Asked Questions

The Company operates in OTC healthcare (pain and congestion management), women’s hygiene (sanitary napkins and related products), beverages (fruit juices and ORS drinks), and runs a pain management centre.

Amrutanjan has 3 plants and 6 offices in India and 1 international office, serving 28 States and 19 countries. Exports contributed 1.67% of turnover in the year ended March 31, 2025 .

The Annual Report states there were no subsidiaries, joint ventures, or associate companies during the year under review. The reporting boundary is on a standalone basis .